-
The federal agency says it is proposing a ban on the use of formaldehyde in hair straighteners and smoothers, which have been linked to increased cancer risks.
-
The FDA asked advisers to take another look at phenylephrine, which became the main drug in over-the-counter decongestants when medicines with an older ingredient were moved behind pharmacy counters.
-
Postpartum depression affects as many as 1 in 7 women in the U.S., though there are just two treatments approved for it. Experts say the newest could be a game-changer — depending on its price tag.
-
Moderate consumption of aspartame is OK, scientists say. But heavy consumers may want to reduce their intake. The WHO says aspartame may "possibly" cause cancer. The FDA questions the evidence.
-
From convenience stores to online, the tablet "will be an available option for millions of people in the United States," the director of the FDA's Center for Drug Evaluation and Research says.
-
A panel of advisers to the Food and Drug Administration has recommended revising the current COVID-19 vaccine so that it specifically targets omicron.
-
Starting June 11, livestock producers will have to get a prescription from a veterinarian to buy antibiotics that they could previously purchase over-the-counter.
-
At least 58,000 childern younger than 5 years old are hospitalized each year with RSV infections. A Pfizer vaccine given to pregnant people could help protect their infants from severe RSV illness.
-
Older adults and others at high risk are now able to get a second shot of the COVID-19 booster that targets omicron.
-
The Food and Drug Administration has new tools to hold drug companies accountable for promises they make about medications. But the agency has yet to show its hand in using this new power.